Robert B. Golbey - Concepedia

Author

Robert B. Golbey

Memorial Sloan Kettering Cancer Center

Also Known As

C E CRANDALL, R B GOLBEY, R B Golbey, R. B. Golbey, R.B. Golbey, ROBERT B. GOLBEY, Robert B. Golbey

Publications

6.2K

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Cornell University Memorial Hospital of South Bend

About

Robert B. Golbey is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	37	4K
2	Health Sciences	12	12	2.1K
3	Gastroenterology	4	4	1K
4	Cell Biology	2	2	178
5	Hepatology	2	2	627

Robert B. Golbey

Publications

5.8K

Citations

H-Index

Page 1

	Year	Citations
High dose Cis-platinum diammine dichloride.Amelioration of renal toxicity by mannitol diuresis Daniel M. Hayes, Esteban Cvitkovic, Robert B. Golbey, Cancer	1977	627
Multivariate Analysis of a Personal Series of 247 Consecutive Patients with Liver Metastases from Colorectal Cancer Joseph G. Fortner, John S. Silva, Robert B. Golbey, Annals of Surgery Surgical OncologyGastroenterologyPathologyCancer RegistrationSurgery	1984	533
Malignant schwannoma—Clinical characteristics, survival, and response to therapy Peter P. Sordillo, Lawrence Helson, Steven I. Hajdu, Cancer Neuro-oncologySurgical OncologyTumoral PathologyMedicineVestibular Schwannoma	1981	405
Cisplatin and Vindesine Combination Chemotherapy for Advanced Carcinoma of the Lung: A Randomized Trial Investigating Two Dosage Schedules Richard J. Gralla, Ephraim S. Casper, David P. Kelsen, Annals of Internal Medicine New AgentsPharmacotherapyMetronomic ChemotherapyDosage SchedulesCancer Chemotherapy	1981	366
Toxicity of E. coli L-asparaginase in man Herbert F. Oettgen, Phyllis A. Stephenson, Morton K. Schwartz, Cancer Food IntolerancePathogenesisNeoplastic DiseaseGastroenterologyPathology	1970	287
A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors. George J. Bosl, Nancy L. Geller, Dean F. Bajorin, Journal of Clinical Oncology Disseminated GctSurgical OncologyGenitourinary CancerMedicineStandard Chemotherapy	1988	253
Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy. Joseph O’Connell, Mark G. Kris, Richard J. Gralla, Journal of Clinical Oncology Advanced NsclcCombination ChemotherapyMedicineCancer ManagementPretreatment Clinical Characteristics	1986	241
Malignant mesothelioma of the pleura: Review of 123 patients Joseph Brenner, Peter P. Sordillo, Gordon B. Magill, Cancer Surgical OncologyPathologyPleural EffusionOncologyPleural Disease	1982	228
VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors. George J. Bosl, R. Gluckman, Nancy L. Geller, Journal of Clinical Oncology Surgical OncologyUrologyGenitourinary CancerMedicineGerm Cell Neoplasia	1986	201
The evolution of mature teratoma from malignant testicular tumors Waun Ki Hong, Robert E. Wittes, Steven T. Hajdu, Cancer	1977	171

Page 1